ManagementPH PHARMA
Hoyoung Huh, M.D., Ph.D.
Founder
- CytomX Therapeutics, Chairman
- Geron Corporation, Chairman
- BiPar Sciences, CEO
- Epizyme, Chairman
- McKinsey & Company, Partner
- Cornell University, M.D., Ph.D.
Jaesoon Kim
Chief Executive Officer
- Daewoong Pharmaceutical, Executive Director
- Hanmi Pharmaceutical, Director
- Mirae Asset Securities, Senior Equity Analyst
- LG Life Sciences, Researcher
- Seoul National University, BS & MS in Pharmacy
Sang Hoon Paik, Ph.D.
Managing Director, Head of Asia Research Center
- GC Green Cross LabCell, Head of Process Unit
- GC Pharma, Principal Scientist / Team Leader
- Korea University, Ph.D. in Biotechnology
Taekyu Park
Managing Director, Management & Operation
- Daewoong Pharmaceutical, Planning & Management Director
- Samil PricewaterhouseCoopers, Director
- Seoul National University, BS
Jae Sik Kim, Ph.D.
Chief Executive Officer
- Avixgen, CEO
- Hanmi Pharmaceutical , SVP
- Daewoong Pharmaceutical, VP
- Samil PricewaterhouseCoopers, Partner & VP
- Kyunghee University , Ph.D.
- KAIST, Master
- Seoul National University, BS
Stephen LaMond, PharmD
Vice President, Business Development
- Corium International, VP BD
- GE Healthcare, CMO
- Zoll Medical, Sr. Director
- Nektar Therapeutics, Sr. Director New Product Planning
- Pfizer, Director-Team Leader New Product Planning, Site Head
- University of Michigan, Ann Arbor, PharmD and MBA
Name
Honorifix
- detail
Name
Honorifix
- detail
Board of DirectorsPH PHARMA
Hoyoung Huh, M.D., Ph.D.
pH Pharma, Chairman & founding CEO
Jaesoon Kim
pH Pharma, CEO
Young-Jin Kim
Handok Inc., Chairman & CEO
SiHyoung Park
SBI Investment, Director
Jungmin Jo
BAE, KIM & LEE LLC , Attorney
Yunsung Koh
HUFS, Professor